Links for this Journal
Medicinally useful proteins enhancing the probability of technical success in the clinic
pp. 149-151(3)
Author:
Armen B Shanafelt
Links for this article
Ethical and regulatory aspects of embryonic stem cell research
pp. 153-162(10)
Author:
KK Jain
Links for this article
Natural killer: can they be useful as adoptive immunotherapy for cancer?
pp. 163-172(10)
Authors:
Sally Arai; Hans-G Klingemann
Links for this article
RNA transfer and its use in dendritic cell-based immunotherapy
pp. 173-181(9)
Authors:
Tatjana C Gust; Martin Zenke
Links for this article
Gene therapy for the treatment of mitochondrial DNA disorders
pp. 183-194(12)
Author:
Robert W Taylor
Links for this article
Development of mammalian artificial chromosomes for the treatment of genetic diseases: Sandhoff and Krabbe diseases
pp. 195-206(12)
Authors:
Bruce A Bunnell; Reza Izadpanah; Harry C Ledebur Jr; Carl F Perez
Links for this article
Antisense approaches for inhibiting respiratory syncytial virus
pp. 207-220(14)
Author:
Hagen Cramer
Links for this article
siRNA as a route to new cancer therapies
pp. 221-224(4)
Authors:
Maya Ameyar-Zazoua; Valentina Guasconi; Slimane Ait-Si-Ali
Links for this article
Recent developments in the production of human therapeutic proteins in eukaryotic algae
pp. 225-235(11)
Authors:
Scott E Franklin; Stephen P Mayfield
Links for this article
TransMabs: cell-penetrating antibodies, the next generation
pp. 237-241(5)
Authors:
Sybille Muller; Yunfeng Zhao; Thomas L Brown; Alton C Morgan; Heinz Kohler
Links for this article
Role of anti-C1q autoantibodies in the pathogenesis of lupus nephritis
pp. 243-251(9)
Authors:
Leendert A Trouw; Mohamed R Daha
Links for this article
From mice to humans murine intelligence for human CD8+ T cell vaccine design
pp. 263-271(9)
Authors:
David C Tscharke; Andreas Suhrbier
Links for this article
Recent developments in Neisseria meningitidis group A conjugate vaccines
pp. 273-280(8)
Author:
Carl E Frasch
Links for this article